Targeting one-carbon metabolism for cancer immunotherapy
Xinxin Ren , Xiang Wang , Guowan Zheng , Shanshan Wang , Qiyue Wang , Mengnan Yuan , Tong Xu , Jiajie Xu , Ping Huang , Minghua Ge
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1521
Targeting one-carbon metabolism for cancer immunotherapy
Background: One-carbon (1C) metabolism is a metabolic network that plays essential roles in biological reactions. In 1C metabolism, a series of nutrients are used to fuel metabolic pathways, including nucleotide metabolism, amino acid metabolism, cellular redox defence and epigenetic maintenance. At present, 1C metabolism is considered the hallmark of cancer. The 1C units obtained from the metabolic pathways increase the proliferation rate of cancer cells. In addition, anticancer drugs, such as methotrexate, which target 1C metabolism, have long been used in the clinic. In terms of immunotherapy, 1C metabolism has been used to explore biomarkers connected with immunotherapy response and immune-related adverse events in patients.
Methods: We collected numerous literatures to explain the roles of one-carbon metabolism in cancer immunotherapy.
Results: In this review, we focus on the important pathways in 1C metabolism and the function of 1C metabolism enzymes in cancer immunotherapy. Then, we summarise the inhibitors acting on 1C metabolism and their potential application on cancer immunotherapy. Finally, we provide a viewpoint and conclusion regarding the opportunities and challenges of targeting 1C metabolism for cancer immunotherapy in clinical practicability in the future.
Conclusion: Targeting one-carbon metabolism is useful for cancer immunotherapy.
cancer immunotherapy / enzymes / inhibitors / one-carbon metabolism
2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
/
| 〈 |
|
〉 |
PDF
